129 related articles for article (PubMed ID: 20659904)
1. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease.
Cardoso EM; Contreras LN; Tumilasci EG; Elbert A; Aguirre EC; Aquilano DR; Arregger AL
Nephrol Dial Transplant; 2011 Feb; 26(2):677-83. PubMed ID: 20659904
[TBL] [Abstract][Full Text] [Related]
2. Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism.
Arregger AL; Contreras LN; Tumilasci OR; Aquilano DR; Cardoso EM
Clin Endocrinol (Oxf); 2007 Nov; 67(5):656-62. PubMed ID: 17953627
[TBL] [Abstract][Full Text] [Related]
3. [Serum and salivary testosterone levels in erectile dysfunction].
Corradi G; Szathmári M
Orv Hetil; 1998 Aug; 139(34):2021-4. PubMed ID: 9745307
[TBL] [Abstract][Full Text] [Related]
4. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism.
Shibayama Y; Higashi T; Shimada K; Odani A; Mizokami A; Konaka H; Koh E; Namiki M
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2615-23. PubMed ID: 19010090
[TBL] [Abstract][Full Text] [Related]
6. Validation of salivary testosterone as a screening test for male hypogonadism.
Morley JE; Perry HM; Patrick P; Dollbaum CM; Kells JM
Aging Male; 2006 Sep; 9(3):165-9. PubMed ID: 17050116
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypogonadism in men with chronic kidney disease.
Johansen KL
Adv Chronic Kidney Dis; 2004 Oct; 11(4):348-56. PubMed ID: 15492971
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of testosterone gel in the treatment of erectile dysfunction in hypogonadal hemodialysis patients: a pilot study.
Cangüven O; Aykose G; Albayrak S; Goktas C; Horuz R; Yencilek F
Int J Impot Res; 2010; 22(2):140-5. PubMed ID: 19924130
[TBL] [Abstract][Full Text] [Related]
9. [Bone and Men's Health. Measurement of salivary testosterone].
Horie S
Clin Calcium; 2010 Feb; 20(2):212-6. PubMed ID: 20118513
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.
Tsujimura A; Matsumiya K; Miyagawa Y; Takao T; Fujita K; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A
Int J Impot Res; 2005; 17(3):259-63. PubMed ID: 15616608
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
12. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
Raynor MC; Carson CC; Pearson MD; Nix JW
Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
[TBL] [Abstract][Full Text] [Related]
13. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
Blümel JE; Chedraui P; Gili SA; Navarro A; Valenzuela K; Vallejo S
Maturitas; 2009 Aug; 63(4):365-8. PubMed ID: 19481382
[TBL] [Abstract][Full Text] [Related]
14. Androgen deficiency in the etiology and treatment of erectile dysfunction.
Gore JL; Swerdloff RS; Rajfer J
Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
[TBL] [Abstract][Full Text] [Related]
15. Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.
Iwamoto T; Yanase T; Horie H; Namiki M; Okuyama A
Int J Urol; 2009 Feb; 16(2):168-74. PubMed ID: 19054164
[TBL] [Abstract][Full Text] [Related]
16. Case report: treatment of androgen deficiency in the aging male.
Hernandez A; Baum N
Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
[TBL] [Abstract][Full Text] [Related]
17. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status.
Goncharov N; Katsya G; Dobracheva A; Nizhnik A; Kolesnikova G; Herbst V; Westermann J
Aging Male; 2006 Jun; 9(2):111-22. PubMed ID: 16916746
[TBL] [Abstract][Full Text] [Related]
19. [Correction of androgen deficiency in elderly patients].
Morgunov LIu
Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
[TBL] [Abstract][Full Text] [Related]
20. Testosterone concentrations in hair of hypogonadal men with and without testosterone replacement therapy.
Thomson S; Koren G; Van Steen V; Rieder M; Van Uum SH
Ther Drug Monit; 2009 Dec; 31(6):779-82. PubMed ID: 19809386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
